Intervenciones educacionales para incrementar la farmacovigilancia en una unidad de salud de familia

Adverse drug reactions (ADRs) are a relevant public health problem and a significant cause of mortality and hospitalization in developed countries, representing about 6.5 % of total hospitalizations [1] . It is estimated that most adverse reactions are detected only in the post-marketing stage, denoting the relevance of a constant drug surveillance system through pharmacovigilance activities after drugs are placed on the market. The Portuguese Pharmacovigilance System is essentially based on the unsolicited notification of suspected ADRs by health professionals to the National Authority, generating warning signs. Despite the legal imperative [2] , the primary limitation to the effectiveness of this notification system is underreporting,